The changes in PL composition induced by the β3-AR agonist may be associated with the previously reported improved insulin sensitivity in adipose tissue [8], and the decrease of hyperinsulinemia measured in the present study. This evidence concerns the gene ADRB3 and Hyperinsulinemia.